MII IG Kerndatensatz-Modul Onkologie
2027.0.0-ballot.1 -
Germany
MII IG Kerndatensatz-Modul Onkologie
2027.0.0-ballot.1 -
Germany
This page is part of the MII IG Kerndatensatz-Modul Onkologie (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
| Offizielle URL: https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-systemische-therapie-substanzen | Version: 2027.0.0-ballot.1 | |||
| Active Stand: 2026-09-15 | Maschinenlesbarer Name: MII_VS_Onko_Systemische_Therapie_Substanzen | |||
Validierte ATC-Codes für Substanzen der systemischen Therapie basierend auf oBDS Umsetzungsleitfaden. Automatisch generiert und gegen MII-Terminologieserver validiert.
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
Profiles: Shareable ValueSet, CRMI Shareable ValueSet, CRMI Publishable ValueSet, CRMI Computable ValueSet
http://fhir.de/CodeSystem/bfarm/atc version Not Stated (use latest from terminology server)| Code | Display |
| L02BX01 | Abarelix |
| L04AA24 | Abatacept |
| L01XE50 | Abemaciclib |
| L01EF03 | Abemaciclib |
| L04AA22 | Abetimus |
| L02BX03 | Abirateron |
| L01XE51 | Acalabrutinib |
| L01EL02 | Acalabrutinib |
| L01DB04 | Aclarubicin |
| L01XX77 | Adagrasib |
| L04AB04 | Adalimumab |
| L01XE13 | Afatinib |
| L01EB03 | Afatinib |
| L04AB03 | Afelimomab |
| L01XX44 | Aflibercept |
| L03AC01 | Aldesleukin |
| L01XE36 | Alectinib |
| L01ED03 | Alectinib |
| L04AA15 | Alefacept |
| L04AA34 | Alemtuzumab |
| L04AG06 | Alemtuzumab |
| M05BA04 | Alendronsäure |
| L01XX22 | Alitretinoin |
| L01XF02 | Alitretinoin |
| L01EM03 | Alpelisib |
| L01XX03 | Altretamin |
| V03AM01 | Amilomer |
| L02BG01 | Aminoglutethimid |
| L01XD04 | Aminolevulinsäure |
| L01FX18 | Amivantamab |
| L01DB10 | Amrubicin |
| L01XX01 | Amsacrin |
| L01XX35 | Anagrelid |
| L04AC03 | Anakinra |
| L02BG03 | Anastrozol |
| L04AA04 | Antithymozytäres Immunglobulin (Kaninchen) |
| L02BB05 | Apalutamid |
| L01XX27 | Arsentrioxid |
| P01BE03 | Artesunat |
| L01EA06 | Asciminib |
| L01XX02 | Asparaginase |
| L01FF05 | Atezolizumab |
| L01EX18 | Avapritinib |
| L01EB11 | Aumolertinib |
| L01FF04 | Avelumab |
| L01XX70 | Axicabtagen Ciloleucel |
| L01XL03 | Axicabtagen ciloleucel |
| L01XE17 | Axitinib |
| L01EK01 | Axitinib |
| L01BC07 | Azacitidin |
| L04AX01 | Azathioprin |
| L04AC02 | Basiliximab |
| L03AX03 | BCG-Impfstoff |
| L01FX15 | Belantamab mafodotin |
| L04AA28 | Belatacept |
| L04AA26 | Belimumab |
| L04AG04 | Belimumab |
| L01XX49 | Belinostat |
| L01XH04 | Belinostat |
| L01XX74 | Belzutifan |
| L01AA09 | Bendamustin |
| L01FG01 | Bevacizumab |
| L01XX25 | Bexaroten |
| L01XF03 | Bexaroten |
| L02BB03 | Bicalutamid |
| L01XE41 | Binimetinib |
| L01EE03 | Binimetinib |
| L01DC01 | Bleomycin |
| L01FX07 | Blinatumomab |
| L01XX32 | Bortezomib |
| L01XG01 | Bortezomib |
| L01XE14 | Bosutinib |
| L01EA04 | Bosutinib |
| L01FX05 | Brentuximab vedotin |
| L01XL06 | Brexucabtagen autoleucel |
| L04AC09 | Briakinumab |
| L01XE43 | Brigatinib |
| L01ED04 | Brigatinib |
| N04BC01 | Bromocriptin |
| L02AE01 | Buserelin |
| L01AB01 | Busulfan |
| L01CD04 | Cabazitaxel |
| N04BC06 | Cabergolin |
| L01XE26 | Cabozantinib |
| L01EX07 | Cabozantinib |
| V03AF04 | Calciumlevofolinat |
| V03AF06 | Natriumfolinat |
| L04AC08 | Canakinumab |
| L01XX86 | Calaspargase pegol |
| L01BC06 | Capecitabin |
| L01EX27 | Capivasertib |
| L01FF14 | Camrelizumab |
| L01EX17 | Capmatinib |
| L01EP01 | Capmatinib |
| L01XA02 | Carboplatin |
| L01AC03 | Carboquon |
| L01XX45 | Carfilzomib |
| L01XG02 | Carfilzomib |
| L01BC04 | Carmofur |
| L01AD01 | Carmustin |
| L01FX03 | Catumaxomab |
| L01FF06 | Cemiplimab |
| L01XE28 | Ceritinib |
| L01ED02 | Ceritinib |
| L04AB05 | Certolizumab pegol |
| H01CC02 | Cetrorelix |
| L01FE01 | Cetuximab |
| L01AA02 | Chlorambucil |
| G03DB06 | Chlormadinon |
| L01AA05 | Chlormethin |
| L04AD01 | Ciclosporin |
| L01XL05 | Ciltacabtagen autoleucel |
| L01XA01 | Cisplatin |
| L01BB04 | Cladribin |
| M05BA02 | Clodronsäure |
| L01BB06 | Clofarabin |
| L01XE38 | Cobimetinib |
| L01EE02 | Cobimetinib |
| L01XX61 | Copanlisib |
| L01EM02 | Copanlisib |
| L01XE16 | Crizotinib |
| L01ED01 | Crizotinib |
| L01AA01 | Cyclophosphamid |
| G03HA01 | Cyproteron |
| L01BC01 | Cytarabin |
| L01XY01 | Cytarabin und Daunorubicin |
| L01XE23 | Dabrafenib |
| L01EC02 | Dabrafenib |
| L01AX04 | Dacarbazin |
| L04AC01 | Daclizumab |
| L01EB07 | Dacomitinib |
| L01DA01 | Dactinomycin |
| L01FC01 | Daratumumab |
| B03XA02 | Darbepoetin alfa |
| L02BB06 | Darolutamid |
| L01XE06 | Dasatinib |
| L01EA02 | Dasatinib |
| L01FX35 | Datopotamab deruxtecan |
| L01DB02 | Daunorubicin |
| L01BC08 | Decitabin |
| L02BX02 | Degarelix |
| L01CC01 | Demecolcin |
| L01XX29 | Denileukindiftitox |
| M05BX04 | Denosumab |
| H02AB02 | Dexamethason |
| L01FX06 | Dinutuximab beta |
| L01CD02 | Docetaxel |
| L01FF07 | Dostarlimab |
| L01DB01 | Doxorubicin |
| L01FF03 | Durvalumab |
| G04CB02 | Dutasterid |
| L01EM04 | Duvelisib |
| L04AA25 | Eculizumab |
| L04AJ01 | Eculizumab |
| L01FX01 | Edrecolomab |
| L04AA21 | Efalizumab |
| L04AG02 | Efalizumab |
| L01XD06 | Efaproxiral |
| L02BA04 | Elacestrant |
| L01FX08 | Elotuzumab |
| B02BX05 | Eltrombopag |
| L01XX59 | Enasidenib |
| L01XM01 | Enasidenib |
| L01XE46 | Encorafenib |
| L01EC03 | Encorafenib |
| L01FF15 | Envafolimab |
| L01FX13 | Enfortumab vedotin |
| L01EX14 | Entrectinib |
| L02BB04 | Enzalutamid |
| L01FX27 | Epcoritamab |
| L01DB03 | Epirubicin |
| L01EN01 | Erdafitinib |
| L01XX41 | Eribulin |
| L01FX36 | Patritumab deruxtecan |
| L01XE03 | Erlotinib |
| L01EB02 | Erlotinib |
| B03XA01 | Erythropoietin |
| L01XX11 | Estramustin |
| L04AB01 | Etanercept |
| M05BA01 | Etidronsäure |
| L01AG01 | Etoglucid |
| L01CB01 | Etoposid |
| L01XE10 | Everolimus |
| L01EG02 | Everolimus |
| L04AH02 | Everolimus |
| L02BG06 | Exemestan |
| L01EJ02 | Fedratinib |
| L03AA02 | Filgrastim |
| G04CB01 | Finasterid |
| L01EB12 | Firmonertinib |
| L04AA27 | Fingolimod |
| L04AE01 | Fingolimod |
| L01BC09 | Floxuridin |
| L01BB05 | Fludarabin |
| L01BC02 | Fluorouracil |
| L01BC52 | Fluorouracil, Kombinationen |
| L02BB01 | Flutamid |
| V03AF03 | Calciumfolinat |
| L02BG02 | Formestan |
| L02AA04 | Fosfestrol |
| B02BX09 | Fostamatinib |
| L01AD05 | Fotemustin |
| L01EK04 | Fruquintinib |
| L02BA03 | Fulvestrant |
| L01EN04 | Futibatinib |
| L01XE02 | Gefitinib |
| L01EB01 | Gefitinib |
| L01BC05 | Gemcitabin |
| L01FX02 | Gemtuzumab ozogamicin |
| L02AB03 | Gestonoron |
| L01XE54 | Gilteritinib |
| L01EX13 | Gilteritinib |
| L01XX63 | Glasdegib |
| L01XJ03 | Glasdegib |
| L04AB06 | Golimumab |
| H01CA01 | Gonadorelin |
| L02AE03 | Goserelin |
| L04AA19 | Gusperimus |
| L03AX14 | Histamindihydrochlorid |
| L02AE05 | Histrelin |
| L01XX05 | Hydroxycarbamid |
| M05BA06 | Ibandronsäure |
| V10XX02 | (90Y)Ibritumomabtiuxetan |
| L01XE27 | Ibrutinib |
| L01EL01 | Ibrutinib |
| L01DB06 | Idarubicin |
| L01XL07 | Idecabtagen vicleucel |
| L01XX47 | Idelalisib |
| L01EM01 | Idelalisib |
| L01AA06 | Ifosfamid |
| L01XE01 | Imatinib |
| L01EA01 | Imatinib |
| L01XX80 | Imetelstat |
| D06BB10 | Imiquimod |
| L01EM06 | Inavolisib |
| L04AB02 | Infliximab |
| D06BX02 | Ingenolmebutat |
| L01FB01 | Inotuzumab ozogamicin |
| L03AB01 | Interferon alfa, natürlich |
| L03AB04 | Interferon alfa-2a |
| L03AB05 | Interferon alfa-2b |
| L03AB18 | Interferon gamma-1b |
| L01FX04 | Ipilimumab |
| L01XX19 | Irinotecan |
| L01CE02 | Irinotecan |
| L01FC02 | Isatuximab |
| L01XX62 | Ivosidenib |
| L01XM02 | Ivosidenib |
| L01DC04 | Ixabepilon |
| L01XX50 | Ixazomib |
| L01XG03 | Ixazomib |
| H02CA03 | Ketoconazol |
| H01CB03 | Lanreotid |
| L01XE07 | Lapatinib |
| L01EH01 | Lapatinib |
| L01XE53 | Larotrectinib |
| L01EX12 | Larotrectinib |
| L01EB09 | Lazertinib |
| L04AA13 | Leflunomid |
| L04AK01 | Leflunomid |
| L04AX04 | Lenalidomid |
| L03AA10 | Lenograstim |
| L01XE29 | Lenvatinib |
| L01EX08 | Lenvatinib |
| L02BG04 | Letrozol |
| L02AE02 | Leuprorelin |
| L01FX37 | Linvoseltamab |
| L03AA14 | Lipegfilgrastim |
| L01XL08 | Lisocabtagen maraleucel |
| L01AD02 | Lomustin |
| A16AX20 | Lonafarnib |
| L01XX07 | Lonidamin |
| L01XE44 | Lorlatinib |
| L01ED05 | Lorlatinib |
| L01XX69 | Lurbinectedin |
| B03XA06 | Luspatercept |
| G03DC03 | Lynestrenol |
| L01AB03 | Mannosulfan |
| J05AX09 | Maraviroc |
| L01FD06 | Margetuximab |
| L01XX10 | Masoprocol |
| L02AB02 | Medroxyprogesteron |
| L02AB01 | Megestrol |
| L01AA03 | Melphalan |
| R03DX09 | Mepolizumab |
| L01BB02 | Mercaptopurin |
| V03AF01 | Mesna |
| N07BC02 | Methadon |
| L01BA01 | Methotrexat |
| L01XD10 | Methoxsalen |
| B03XA03 | Methoxy-Polyethylenglycol-Epoetin beta |
| L01XD03 | Methylaminolevulinat |
| H02AB04 | Methylprednisolon |
| L01XE39 | Midostaurin |
| L01EX10 | Midostaurin |
| L01EE05 | Mirdametinib |
| L03AX15 | Mifamurtid |
| L01XX09 | Miltefosin |
| L01CH01 | Mistelkraut |
| L01CP01 | Mistelkraut |
| L01AX01 | Mitobronitol |
| L01XX16 | Mitoguazon |
| L01DC03 | Mitomycin |
| L01XX23 | Mitotan |
| L01DB07 | Mitoxantron |
| L01EB10 | Mobocertinib |
| L01FX09 | Mogamulizumab |
| L03AA03 | Molgramostim |
| L01FX24 | Teclistamab |
| L01FX25 | Mosunetuzumab |
| L01FB02 | Moxetumomab pasudotox |
| L04AA02 | Muromonab-CD3 |
| L04AG01 | Muromonab-CD3 |
| L04AA06 | Mycophenolsäure |
| L04AA23 | Natalizumab |
| L04AG03 | Natalizumab |
| V03AF10 | Natriumlevofolinat |
| L01XX78 | Navitoclax |
| L01FE03 | Necitumumab |
| L01BB07 | Nelarabin |
| L01XE45 | Neratinib |
| L01EH02 | Neratinib |
| L01XE08 | Nilotinib |
| L01EA03 | Nilotinib |
| L02BB02 | Nilutamid |
| L01AD06 | Nimustin |
| L01XX81 | Nirogacestat |
| L01XE31 | Nintedanib |
| L01EX09 | Nintedanib |
| L01XX54 | Niraparib |
| L01XK02 | Niraparib |
| L01FF01 | Nivolumab |
| L01XY03 | Nivolumab und Relatlimab |
| L01FY02 | Nivolumab und Relatlimab |
| L01FA03 | Obinutuzumab |
| L01XX36 | Oblimersen |
| L01XL12 | Obecabtagen autoleucel |
| H01CB02 | Octreotid |
| L01FX34 | Odronextamab |
| L01FA02 | Ofatumumab |
| L04AG12 | Ofatumumab |
| L01XX46 | Olaparib |
| L01XK01 | Olaparib |
| L01FX10 | Olaratumab |
| L01XX40 | Omacetaxinmepesuccinat |
| L01FX16 | Oportuzumab monatox |
| L03AC02 | Oprelvekin |
| L01XE35 | Osimertinib |
| L01EB04 | Osimertinib |
| L01XA03 | Oxaliplatin |
| L01CD01 | Paclitaxel |
| L01CD03 | Paclitaxelpoliglumex |
| L01EJ03 | Pacritinib |
| L01XE33 | Palbociclib |
| L01EF01 | Palbociclib |
| V03AF08 | Palifermin |
| M05BA03 | Pamidronsäure |
| L01FE02 | Panitumumab |
| L01XX42 | Panobinostat |
| L01XH03 | Panobinostat |
| L01EX03 | Pazopanib |
| L01XX24 | Pegaspargase |
| L03AA13 | Pegfilgrastim |
| L03AB11 | Peginterferon alfa-2a |
| L03AB10 | Peginterferon alfa-2b |
| L01FF02 | Pembrolizumab |
| L01BA04 | Pemetrexed |
| L01EN02 | Pemigatinib |
| L01XX84 | Pelabresib |
| L01XX08 | Pentostatin |
| L01FD02 | Pertuzumab |
| L01XY02 | Pertuzumab und Trastuzumab |
| L01FY01 | Pertuzumab und Trastuzumab |
| L01AX02 | Pipobroman |
| L01DB08 | Pirarubicin |
| L01DB11 | Pixantron |
| V03AX10 | Placebo |
| L03AX16 | Plerixafor |
| L01DC02 | Plicamycin |
| L01FX14 | Polatuzumab vedotin |
| L03AX08 | Poly ICLC |
| L02AA02 | Polyestradiolphosphat |
| L01XA05 | Polyplatillen |
| L04AX06 | Pomalidomid |
| L01XE24 | Ponatinib |
| L01EA05 | Ponatinib |
| L01XD01 | Porfimer natrium |
| L01BA05 | Pralatrexat |
| L01EX23 | Pralsetinib |
| D07AC18 | Prednicarbat |
| L01AA08 | Prednimustin |
| H02AB06 | Prednisolon |
| H02AB07 | Prednison |
| L01XB01 | Procarbazin |
| D05AD | Psoralene zur topischen Anwendung |
| D05BA | Psoralene zur systemischen Anwendung |
| L01XE52 | Quizartinib |
| L01EX11 | Quizartinib |
| G03XC01 | Raloxifen |
| L01BA03 | Raltitrexed |
| L01FG02 | Ramucirumab |
| L01AD07 | Ranimustin |
| L01XE21 | Regorafenib |
| L01EX05 | Regorafenib |
| L02BX04 | Relugolix |
| L01FF10 | Retifanlimab |
| L01XE42 | Ribociclib |
| L01EK05 | Rivoceranib |
| L01EF02 | Ribociclib |
| L04AC04 | Rilonacept |
| L01EX19 | Ripretinib |
| M05BA07 | Risedronsäure |
| L01FA01 | Rituximab |
| L01XH02 | Romidepsin |
| L01XX39 | Romidepsin |
| B02BX04 | Romiplostim |
| L03AB15 | Ropeginterferon alfa-2b |
| L01XK03 | Rucaparib |
| L01XE18 | Ruxolitinib |
| L01EJ01 | Ruxolitinib |
| L01FX19 | Sabatolimab |
| L01EP03 | Savolitinib |
| L01FX17 | Sacituzumab govitecan |
| L01XA04 | Satraplatin |
| L01XX66 | Selinexor |
| L01EX22 | Selpercatinib |
| L01EE04 | Selumetinib |
| L01AD03 | Semustin |
| L04AC11 | Siltuximab |
| L04AA10 | Sirolimus |
| L04AH01 | Sirolimus |
| L01XL01 | Sitimagen ceradenovec |
| H01CB01 | Somatostatin |
| L01XJ02 | Sonidegib |
| L01EX02 | Sorafenib |
| L01XE05 | Sorafenib |
| L01XX73 | Sotorasib |
| L01AD04 | Streptozocin |
| L01FF11 | Sugemalimab |
| L01XE04 | Sunitinib |
| L01EX01 | Sunitinib |
| L04AD02 | Tacrolimus |
| L01FX12 | Tafasitamab |
| L01XX67 | Tagraxofusp |
| L01XX60 | Talazoparib |
| L01XK04 | Talazoparib |
| L01XX51 | Talimogen laherparepvec |
| L01XL02 | Talimogen laherparepvec |
| L01FX29 | Talquetamab |
| L02BA01 | Tamoxifen |
| L03AX11 | Tasonermin |
| L01XX72 | Tazemetostat |
| L01XX75 | Tebentafusp |
| L01BC53 | Tegafur, Kombinationen |
| L01BC63 | Tegafur und Uracil |
| L01BC73 | Tegafur, Gimeracil und Oteracil |
| L01XD05 | Temoporfin |
| L01AX03 | Temozolomid |
| L01XE09 | Temsirolimus |
| L01EG01 | Temsirolimus |
| L01CB02 | Teniposid |
| L01EX21 | Tepotinib |
| L01EP02 | Tepotinib |
| L04AX02 | Thalidomid |
| L01AC01 | Thiotepa |
| L01XX18 | Tiazofurin |
| M05BA05 | Tiludronsäure |
| L01BB03 | Tioguanin |
| L01XX71 | Tisagenlecleucel |
| L01XL04 | Tisagenlecleucel |
| L01FF09 | Tislelizumab |
| L01XE34 | Tivozanib |
| L01EK03 | Tivozanib |
| L04AC07 | Tocilizumab |
| L01XX17 | Topotecan |
| L01CE01 | Topotecan |
| L02BA02 | Toremifen |
| L01FF13 | Toripalimab |
| L01EC04 | Tovorafenib |
| V10XA53 | Tositumomab/(131I)Iodtositumomab |
| L01CX01 | Trabectedin |
| L01XE25 | Trametinib |
| L01EE01 | Trametinib |
| L01FD01 | Trastuzumab |
| L01FD04 | Trastuzumab deruxtecan |
| L01FD05 | Trastuzumab duocarmazin |
| L01FD03 | Trastuzumab emtansin |
| L01FX20 | Tremelimumab |
| L01AB02 | Treosulfan |
| L01XX14 | Tretinoin |
| L01XF01 | Tretinoin |
| L01AC02 | Triaziquon |
| L01BC59 | Trifluridin, Kombinationen |
| L02AE04 | Triptorelin |
| L01AA07 | Trofosfamid |
| L01EE06 | Tunlametinib |
| L01EH03 | Tucatinib |
| L01AD08 | Uramustin |
| N03AG01 | Valproinsäure |
| L01DB09 | Valrubicin |
| L01XE12 | Vandetanib |
| L01EX04 | Vandetanib |
| L01XK05 | Veliparib |
| L01XE15 | Vemurafenib |
| L01EC01 | Vemurafenib |
| L01XX52 | Venetoclax |
| L01CA01 | Vinblastin |
| L01CA02 | Vincristin |
| L01CA03 | Vindesin |
| L01EX29 | Vimseltinib |
| L01CA05 | Vinflunin |
| L01CA04 | Vinorelbin |
| L01XJ01 | Vismodegib |
| L01XX43 | Vismodegib |
| L04AD03 | Voclosporin |
| L01XM04 | Vorasidenib |
| L01XX38 | Vorinostat |
| L01XH01 | Vorinostat |
| L02BG05 | Vorozol |
| L01XX53 | Vosaroxin |
| L01EL03 | Zanubrutinib |
| L01EH04 | Zongertinib |
| L01FX31 | Zolbetuximab |
| M05BA08 | Zoledronsäure |
| L01DB05 | Zorubicin |
Expansion from 127.0.0.1 based on codesystem atc version 2026
This value set contains 445 concepts